Tweenvest Stocks

Oncology Pharma Inc. (OTCPK: ONPH)

Health Care · Biotechnology · US

$0.05

+4.00% today · +5100.0% 1Y

Oncology Pharma Inc. (OTCPK: ONPH) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.01M and employs 1 people.

Over the last twelve months the share price has gained 5100.0%, trading between 0.00 and 0.36.

Tweenvest scores Oncology Pharma Inc. across four factors: quality 53/100. Its strongest factor is quality.

ONPH price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$2.01M
Revenue (TTM)
$10.21K
P/E
—
EPS
—
Dividend yield
—
Beta (5Y)
-6.35
52-week high
$0.36
52-week low
$0.00
Avg volume (3M)
—
Shares outstanding
38.66M
Employees
1
Next earnings
—

About Oncology Pharma Inc.

Oncology Pharma Inc. is a pharmaceutical firm specializing in oncology, dedicated to the development, manufacturing, and commercialization of therapeutic agents. The company has a collaborative and licensing agreement with Kalos Therapeutics Inc. to explore treatment possibilities for the COVID-19 virus. Originally incorporated in 1993, the company was known as SourcingLink.net Inc. until it rebranded as Oncology Pharma Inc. in June 2019. Its operations are based in San Francisco, California.

ISIN
US68235J2015
Founded
1993
Listed since
Oct 31, 1994
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
HBL - Hadasit Bio-Holdings LtdTASE: HDST-M$2.16M₪0.60—
CASI Pharmaceuticals, Inc.OTCPK: CASI.F$2.06M$0.10-9.00%
Transgene Biotek LimitedBSE: 526139$2.04MRs2.55+3.24%
Kairos Pharma, Ltd.NYSEAM: KAPA$2.04M$0.60-25.79%
Anatara Lifesciences LtdASX: ANR$1.98MAU$0.01-10.00%
Oragenics, Inc.NYSEAM: OGEN$1.96M$0.43-4.63%
BioRestorative Therapies, Inc.NasdaqCM: BRTX$1.96M$1.54-19.37%
Revelation Biosciences, Inc.NasdaqCM: REVB$1.93M$0.48-36.22%

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.